human anti-d immunoglobulin
PolandDrugs containing this active substance
-
The medicine is used to prevent hemolytic disease of the newborn in women with Rh-negative blood groups. It works by inhibiting the mother's immune response to antigens present in the fetal blood cells.
Form: solution for injection
Active substance Dosage human anti-d immunoglobulin 150 mcg ATC: J06BB01
Manufacturer: Synthaverse S.A.
-
The medicine is used to prevent the production of anti-D antibodies in the body of an Rh-negative woman. It is administered following a miscarriage, abortion, or ectopic pregnancy removal.
Form: solution for injection
Active substance Dosage human anti-d immunoglobulin 50 mcg ATC: J06BB01
Manufacturer: Synthaverse S.A.
-
The medicine is used in women with Rh-negative blood group to prevent the production of antibodies that could harm the unborn baby (especially in subsequent pregnancies). It is administered, among other things, after the birth of an Rh-positive child, in cases of miscarriage, ectopic pregnancy, or after certain medical procedures during pregnancy.
Form: solution for injection
Active substance Dosage human anti-d immunoglobulin 750 IU/ml ATC: J06BB01
Manufacturer: Octapharma AB
-
The medicine is used to prevent the formation of antibodies in individuals with Rh(D) negative blood group who have been exposed to Rh(D) positive blood. This primarily concerns pregnant women (in case of risk of contact with the baby's blood, e.g., after childbirth, miscarriage, or pregnancy complications) as well as adults and children who have accidentally received the wrong blood group during a transfusion.
Form: solution for injection
Active substance Dosage human anti-d immunoglobulin 300 mcg (1500IU)/2 ml ATC: J06BB01
Manufacturer: CSL Behring GmbH